Strbova J, Kmecova J, Klimas J
Hospital of Ministry of Internal Affairs, Department of Functional Diagnostics, Bratislava, Slovakia.
Bratisl Lek Listy. 2011;112(10):562-7.
We tested whether antihypertensive therapy may alter PP independently from other blood pressure parameters.
Data from 24-hour ambulatory blood pressure monitoring (24-h ABPM) were compared between healthy normotensive controls and hypertensive subjects successfully treated (sBP/dBP 24-hour average bellow 130/80 mmHg) with antihypertensive medication either with absence (Treated) or presence of additional risk factors (Treated + R). These groups were compared with poorly treated hypertensives (sBP/dBP over 130/80 mmHg) with absence (Uncontrolled) or presence of additional risk factors (Uncontrolled + R). We studied mean 24-hour systolic and diastolic blood pressure (sBP and dBP), mean arterial pressure (MAP) and pulse pressure (PP).
In Treated and Treated + R groups, sBP and dBP were appropriately controlled by antihypertensive medication, however PP was significantly increased in both groups (49 +/- 1 mmHg and 51 +/- 2 mmHg, resp., in both p < 0.05) as compared to the controls (43 +/- 1 mmHg). In Uncontrolled and Uncontrolled + R groups, values of PP were even significantly higher (60 +/- 2 mmHg and 76 +/- 3, resp.) as compared to controls as well as to successfully treated groups (p < 0.05). PP was significantly positively correlated to sBP in all groups (p < 0.05), except Treated + R. Other parameters (age, body mass index, MAP) showed overall significant positive relationship only in pooled hypertensive population.
24-h ABPM revealed significantly increased PP, in spite of proper control of sBP and dBP in treated hypertensive patients. We propose that 24-h PP could provide additional information in the evaluation of antihypertensive therapy, even when depending on sBP (Tab. 3, Fig. 2, Ref. 39).
我们测试了降压治疗是否能独立于其他血压参数改变脉压(PP)。
比较健康血压正常对照组与使用降压药物成功治疗(24小时平均收缩压/舒张压低于130/80 mmHg)的高血压患者的24小时动态血压监测(24-h ABPM)数据,这些高血压患者分为无其他危险因素组(治疗组)和有其他危险因素组(治疗+危险因素组)。将这些组与治疗不佳的高血压患者(收缩压/舒张压超过130/80 mmHg)进行比较,后者也分为无其他危险因素组(未控制组)和有其他危险因素组(未控制+危险因素组)。我们研究了24小时平均收缩压和舒张压(sBP和dBP)、平均动脉压(MAP)和脉压(PP)。
在治疗组和治疗+危险因素组中,降压药物适当控制了收缩压和舒张压,但与对照组(43±1 mmHg)相比,两组的脉压均显著升高(分别为49±1 mmHg和51±2 mmHg,p均<0.05)。在未控制组和未控制+危险因素组中,与对照组以及成功治疗组相比,脉压值甚至更高(分别为60±2 mmHg和76±3 mmHg,p<0.05)。除治疗+危险因素组外,所有组的脉压与收缩压均呈显著正相关(p<0.05)。其他参数(年龄、体重指数、平均动脉压)仅在合并的高血压人群中总体呈显著正相关。
24小时动态血压监测显示,尽管治疗的高血压患者收缩压和舒张压得到了适当控制,但脉压仍显著升高。我们认为,即使依赖于收缩压,24小时脉压也可为降压治疗的评估提供额外信息(表3,图2,参考文献39)。